Home › Funds › Marshall Wace › PLRX
Marshall Wace position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)835.12K sh
Reported value held$952.04K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 46.41K | $371.00K | New |
| Q4 2022 | 65.82K | $1.27M | New |
| Q1 2023 | 37.35K | $993.62K | Reduce |
| Q3 2023 | 73.92K | $1.28M | New |
| Q1 2024 | 130.94K | $1.95M | New |
| Q4 2024 | 53.88K | $709.60K | New |
| Q1 2025 | 208.53K | $281.52K | Add |
| Q3 2025 | 299.46K | $443.20K | New |
| Q4 2025 | 1.08M | $1.32M | Add |
| Q1 2026 | 995.97K | $1.25M | Reduce |
| Q2 2026 | 835.12K | $952.04K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Citadel Advisors 2.14M sh · $2.44M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- BlackRock Inc 1.15M sh · $1.31M · Q2 2026
- JPMorgan Chase & Co 681.65K sh · $783.89K · Q2 2026
- Geode Capital Management 578.58K sh · $659.95K · Q2 2026
- UBS Group AG 571.76K sh · $651.81K · Q2 2026
- Millennium Management 559.45K sh · $637.77K · Q2 2026
- Morgan Stanley 298.98K sh · $340.83K · Q2 2026
- Goldman Sachs Group 208.59K sh · $237.79K · Q2 2026